Johns Hopkins Pancreatic Cancer Vaccine Shows 90% Immune Response
Johns Hopkins researchers have developed a promising pancreatic cancer vaccine. Early trials show that the vaccine triggers a robust immune response in 90% of…
Tag
Deep-dive articles with this tag.
Johns Hopkins researchers have developed a promising pancreatic cancer vaccine. Early trials show that the vaccine triggers a robust immune response in 90% of…